Sitagliptin is an oral antihyperglycemic (antidiabetic drug) of the dipeptidyl
peptidase-4 (DPP-4) inhibitor class. It was developed, and is marketed, by Merck
Easy to read patient leaflet for sitagliptin. Includes indications, proper use, special
instructions, precautions, and possible side effects.
Find information about a once-daily prescription pill, that along with diet and
exercise, may help lower blood sugar levels in adults with type 2 diabetes.
Sep 8, 2016 ... Learn about Januvia (Sitagliptin Phosphate) may treat, uses, dosage, side effects
, drug interactions, warnings, patient labeling, reviews, and ...
May 16, 2007 ... Description, Sitagliptin is a new oral hypoglycemic (anti-diabetic drug) of the new
dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs.
Sitagliptin is an antidiabetic used to treat diabetes. Read about sitagliptin and it's
side effects and dosage information online at Patient.
Dec 24, 2014 ... Read about Januvia (sitagliptin), the diabetes medication that reduces blood
sugar levels in individuals with type 2 diabetes.
Sitagliptin is a pyrazine-derived DIPEPTIDYL-PEPTIDASE IV INHIBITOR and
HYPOGLYCEMIC AGENT that increases the levels of the INCRETIN hormones ...
Cardiol Rev. 2007 Sep-Oct;15(5):264-71. Sitagliptin: a novel drug for the
treatment of type 2 diabetes. Choy M(1), Lam S. Author information: (1)
Department of ...
Mar 14, 2016 ... However, because sitagliptin is primarily renally eliminated, severe hepatic
impairment is not expected to affect the pharmacokinetics of ...